CoChat
Sign Up
Cited by 408

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The F-Box Protein Skp2 Participates in c-Myc Proteosomal Degradation and Acts as a Cofactor for c-Myc-Regulated Transcription

von der Lehr, Natalie, Johansson, Sara, Wu, Siqin, Bahram, Fuad, Castell, Alina, Cetinkaya, Cihan, Hydbring, Per, Weidung, Ingrid, Nakayama, Keiko, Nakayama, Keiichi I, Söderberg, Ola, Kerppola, Tom K, Larsson, Lars-Gunnar·2003·Molecular Cell
DOI 10.1016/s1097-2765(03)00193-x
Open this paper in CoChat — free account

Abstract

The transcription regulatory oncoprotein c-Myc controls genes involved in cell growth, apoptosis, and oncogenesis. c-Myc is turned over very quickly through the ubiquitin/proteasome pathway. The proteins involved in this process are still unknown. We have found that Skp2 interacts with c-Myc and participates in its ubiquitylation and degradation. The interaction between Skp2 and c-Myc occurs during the G1 to S phase transition of the cell cycle in normal lymphocytes. Surprisingly, Skp2 enhances c-Myc-induced S phase transition and activates c-Myc target genes in a Myc-dependent manner. Further, Myc-induced transcription was shown to be Skp2 dependent, suggesting interdependence between c-Myc and Skp2 in activation of transcription. Moreover, Myc-dependent association of Skp2, ubiquitylated proteins, and subunits of the proteasome to a c-Myc target promoter was demonstrated in vivo. The results suggest that Skp2 is a transcriptional cofactor for c-Myc and indicates a close relationship between transcription activation and transcription factor ubiquitination.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1097-2765(03)00193-x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 38

  1. Amati, 2001, Function of the c-Myc oncoprotein in chromatin remodeling and transcription, Biochim. Biophys. Acta, 1471, M135
  2. Bahram, 1999, Posttranslational regulation of Myc function in response to phorbol ester/interferon-gamma-induced differentiation of v-Myc-transformed U-937 monoblasts, Blood, 93, 3900, 10.1182/blood.V93.11.3900 · DOI
  3. Bahram, 2000, c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover, Blood, 95, 2104, 10.1182/blood.V95.6.2104 · DOI
  4. Beier, 2000, Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events, EMBO J., 19, 5813, 10.1093/emboj/19.21.5813 · DOI
  5. Bouchard, 2001, Regulation of cyclin D2 gene expression by the Myc/Max/Mad network, Genes Dev., 15, 2042, 10.1101/gad.907901 · DOI
  6. Brower, 2002, Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase, Proc. Natl. Acad. Sci. USA, 99, 10353, 10.1073/pnas.162424199 · DOI
  7. Carrano, 1999, SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27, Nat. Cell Biol., 1, 193, 10.1038/12013 · DOI
  8. Chi, 2001, Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase, Genes Dev., 15, 1078, 10.1101/gad.867501 · DOI
  9. Conaway, 2002, Emerging roles of ubiquitin in transcription regulation, Science, 296, 1254, 10.1126/science.1067466 · DOI
  10. DeSalle, 2001, Regulation of the G1 to S transition by the ubiquitin pathway, FEBS Lett., 490, 179, 10.1016/S0014-5793(01)02121-4 · DOI
  11. Desbarats, 1996, Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc, Genes Dev., 10, 447, 10.1101/gad.10.4.447 · DOI
  12. Elbashir, 2001, Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 411, 494, 10.1038/35078107 · DOI · Paper page
  13. Ferdous, 2001, The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II, Mol. Cell, 7, 981, 10.1016/S1097-2765(01)00250-7 · DOI
  14. Flinn, 1998, myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome, Mol. Cell. Biol., 18, 5961, 10.1128/MCB.18.10.5961 · DOI
  15. Frank, 2001, Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation, Genes Dev., 15, 2069, 10.1101/gad.906601 · DOI
  16. Grandori, 2000, The Myc/Max/Mad network and the transcriptional control of cell behavior, Annu. Rev. Cell Dev. Biol., 16, 653, 10.1146/annurev.cellbio.16.1.653 · DOI · Paper page
  17. Gregory, 2000, c-Myc proteolysis by the ubiquitin-proteasome pathway, Mol. Cell. Biol., 20, 2423, 10.1128/MCB.20.7.2423-2435.2000 · DOI
  18. Gstaiger, 2001, Skp2 is oncogenic and overexpressed in human cancers, Proc. Natl. Acad. Sci. USA, 98, 5043, 10.1073/pnas.081474898 · DOI
  19. Hershko, 1998, The ubiquitin system, Annu. Rev. Biochem., 67, 425, 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
  20. Hu, 2002, Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation, Mol. Cell, 9, 789, 10.1016/S1097-2765(02)00496-3 · DOI
  21. Kaiser, 2000, Regulation of transcription by ubiquitination without proteolysis, Cell, 102, 303, 10.1016/S0092-8674(00)00036-2 · DOI
  22. Kato, 1990, An amino-terminal c-myc domain required for neoplastic transformation activates transcription, Mol. Cell. Biol., 10, 5914, 10.1128/MCB.10.11.5914 · DOI
  23. Kuras, 2002, Dual regulation of the met4 transcription factor by ubiquitin-dependent degradation and inhibition of promoter recruitment, Mol. Cell, 10, 69, 10.1016/S1097-2765(02)00561-0 · DOI
  24. Latres, 2001, Role of the F-box protein Skp2 in lymphomagenesis, Proc. Natl. Acad. Sci. USA, 98, 2515, 10.1073/pnas.041475098 · DOI
  25. Lisztwan, 1998, Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2), EMBO J., 17, 368, 10.1093/emboj/17.2.368 · DOI
  26. Mateyak, 1997, Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination, Cell Growth Differ., 8, 1039
  27. Molinari, 1999, Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo, EMBO J., 18, 6439, 10.1093/emboj/18.22.6439 · DOI
  28. Muratani, 2003, How the ubiquitin-proteasome system controls transcription, Nat. Rev. Mol. Cell Biol., 4, 192, 10.1038/nrm1049 · DOI · Paper page
  29. Nakayama, 2000, Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication, EMBO J., 19, 2069, 10.1093/emboj/19.9.2069 · DOI
  30. Ottosen, 2002, Transcription. Proteasome parts at gene promoters, Science, 296, 479, 10.1126/science.1071270 · DOI
  31. Salghetti, 1999, Destruction of Myc by ubiquitin-mediated proteolysis, EMBO J., 18, 717, 10.1093/emboj/18.3.717 · DOI
  32. Salghetti, 2000, Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis, Proc. Natl. Acad. Sci. USA, 97, 3118, 10.1073/pnas.97.7.3118 · DOI
  33. Salghetti, 2001, Regulation of transcriptional activation domain function by ubiquitin, Science, 293, 1651, 10.1126/science.1062079 · DOI
  34. Sears, 1999, Ras enhances Myc protein stability, Mol. Cell, 3, 169, 10.1016/S1097-2765(00)80308-1 · DOI
  35. Sutterluty, 1999, p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells, Nat. Cell Biol., 1, 207, 10.1038/12027 · DOI
  36. Treier, 1994, Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain, Cell, 78, 787, 10.1016/S0092-8674(94)90502-9 · DOI
  37. Weissman, 2001, Themes and variations on ubiquitylation, Nat. Rev. Mol. Cell Biol., 2, 169, 10.1038/35056563 · DOI
  38. Zeller, 2001, Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation, J. Biol. Chem., 276, 48285, 10.1074/jbc.M108506200 · DOI

Cited by

Metadata

Authors
von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., Hydbring, P., Weidung, I., Nakayama, K., Nakayama, K. I., Söderberg, O., Kerppola, T. K., & Larsson, L.-G.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2003-05
Volume
11
Issue
5
Pages
1189-1200
ISSN
1097-2765
DOI
10.1016/s1097-2765(03)00193-x
Cited by
408
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review